Scholarlink

Background <p>Patients with chronic kidney disease (CKD) are susceptible to acquiring opportunistic parasites due to acquired immunodeficiency caused by uremia. Therefore, the present case–control study attempted to determine the prevalence of <i>T. gondii</i> infection and also associated risk factors among patients with CKD under hemodialysis and healthy controls who were registered at the Iranian National Registry Center for Toxoplasmosis (INRCT) in Mazandaran Province, northern Iran.</p> Methods <p>212 cases with CKD and 200 healthy controls were enrolled in this study. Informed consent as well as a questionnaire were obtained from all subjects. Blood samples were collected from each participant and the serum was screened for anti-<i>Toxoplasma</i> antibodies (IgG and IgM). PCR assay was performed to detect circulating <i>T. gondii</i> in the blood samples of patients and controls using the primer pair targeting the RE gene.</p> Results <p>Out of 412 participants, 67.92% of patients and 15.5% of control subjects were positive for anti-<i>Toxoplasma</i> IgG, but all participants were negative for anti-<i>Toxoplasma</i> IgM. Also, considering PCR assays with RE target, the prevalence of <i>T. gondii</i> infection was 24.1% in case subjects, while none of the control subjects tested positive. Among the PCR positive, 34 (66.7%) had <i>Toxoplasma</i> IgG positivity. The results from the multiple multinomial logistic regression revealed that the seroprevalence of anti-<i>T. gondii</i> IgG antibodies in patients with CKD was 3.12 times higher than in healthy controls (OR = 3.12; 95% CI = 0.43, 14.8; <i>P &lt;</i> 0.001). Also, there was a significant association between seroprevalence of <i>T. gondii</i> infection and age, having a cat at home, and level of glomerular filtration rate (GFR) in these patients.</p> Conclusion <p>Our findings demonstrate a highly significant association between latent <i>T. gondii</i> infection and CKD, mostly in the late stages. Thus, regular screening for <i>T. gondii</i> infection in these patients is strongly recommended to prevent the reactivation of latent infections. A combination of serological screening, chemoprophylaxis, and PCR follow-up for patients at risk of reactivation should effectively reduce the likelihood of latent infection reactivation.</p> Clinical trial number <p>Not applicable.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Latent Toxoplasma gondii infection and associated risk factors among patients with chronic kidney disease: a registry-based study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年3月31日

查看全文
  • Mahbobeh Montazeri,
  • Mahdi Fakhar,
  • Omid Sedighi,
  • Atieh Makhlough,
  • Rabeeh Tabaripour,
  • Maryam Nakhaei,
  • Mostafa Soleymani

摘要

Background

Patients with chronic kidney disease (CKD) are susceptible to acquiring opportunistic parasites due to acquired immunodeficiency caused by uremia. Therefore, the present case–control study attempted to determine the prevalence of T. gondii infection and also associated risk factors among patients with CKD under hemodialysis and healthy controls who were registered at the Iranian National Registry Center for Toxoplasmosis (INRCT) in Mazandaran Province, northern Iran.

Methods

212 cases with CKD and 200 healthy controls were enrolled in this study. Informed consent as well as a questionnaire were obtained from all subjects. Blood samples were collected from each participant and the serum was screened for anti-Toxoplasma antibodies (IgG and IgM). PCR assay was performed to detect circulating T. gondii in the blood samples of patients and controls using the primer pair targeting the RE gene.

Results

Out of 412 participants, 67.92% of patients and 15.5% of control subjects were positive for anti-Toxoplasma IgG, but all participants were negative for anti-Toxoplasma IgM. Also, considering PCR assays with RE target, the prevalence of T. gondii infection was 24.1% in case subjects, while none of the control subjects tested positive. Among the PCR positive, 34 (66.7%) had Toxoplasma IgG positivity. The results from the multiple multinomial logistic regression revealed that the seroprevalence of anti-T. gondii IgG antibodies in patients with CKD was 3.12 times higher than in healthy controls (OR = 3.12; 95% CI = 0.43, 14.8; P < 0.001). Also, there was a significant association between seroprevalence of T. gondii infection and age, having a cat at home, and level of glomerular filtration rate (GFR) in these patients.

Conclusion

Our findings demonstrate a highly significant association between latent T. gondii infection and CKD, mostly in the late stages. Thus, regular screening for T. gondii infection in these patients is strongly recommended to prevent the reactivation of latent infections. A combination of serological screening, chemoprophylaxis, and PCR follow-up for patients at risk of reactivation should effectively reduce the likelihood of latent infection reactivation.

Clinical trial number

Not applicable.